{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:40:10Z","timestamp":1785559210989,"version":"3.56.0"},"reference-count":61,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>HLA class I\u2013immunized patients can experience a serious complication known as platelet transfusion refractoriness (PTR). This issue becomes especially relevant in onco-hematology departments where platelet transfusions are at the heart of patient care. Although transfusion failure is evidenced by a rapid elimination of allogeneic platelets from the recipient\u2019s bloodstream, the mechanisms behind it remain poorly characterized. The aim of this study was to better define these mechanisms to improve therapy for PTR. Using a murine model of major histocompatibility complex class I incompatibility to mimic PTR, we first established that antibodies, but not natural killer or CD8 cells, mediated platelet clearance. However, blocking Fc\u03b3 receptors with intravenous immunoglobulin or a monoclonal antibody or complement depletion did not correct refractoriness in alloimmune mice. Therefore, we investigated other alternatives beyond antibody-dependent mechanisms. Flow cytometric and microscopic analysis showed that Kupffer cells in the liver and red pulp macrophages in the spleen phagocytose allogeneic platelets during PTR. Moreover, intravital microscopy revealed allogeneic platelets retained in close interaction with macrophages in the red pulp only in alloimmune animals. Splenectomy or Kupffer cell depletion with clodronate in alloimmune mice suggested the existence of compensatory elimination mechanisms in the liver and spleen. Therefore, the simultaneous removal of both macrophage populations was an effective strategy to abrogate PTR. Our study provides an insight into the mechanisms of platelet clearance in alloimmune pathologies and opens up new perspectives for therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017175","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:11:03Z","timestamp":1760123463000},"page":"367-378","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Targeting macrophages prevents alloantibody-mediated platelet clearance in a murine model of transfusion refractoriness"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3370-5894","authenticated-orcid":false,"given":"Gabriel","family":"Rojas-Jim\u00e9nez","sequence":"first","affiliation":[{"name":"1Universit\u00e9 de Strasbourg, Strasbourg, France"},{"name":"2INSERM UMR_S1255, Strasbourg, France"},{"name":"3\u00c9tablissement Fran\u00e7ais du Sang-Grand Est F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-1165","authenticated-orcid":false,"given":"Catherine","family":"Ang\u00e9nieux","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 de Strasbourg, Strasbourg, France"},{"name":"2INSERM UMR_S1255, Strasbourg, France"},{"name":"3\u00c9tablissement Fran\u00e7ais du Sang-Grand Est F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Proamer","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 de Strasbourg, Strasbourg, France"},{"name":"2INSERM UMR_S1255, Strasbourg, France"},{"name":"3\u00c9tablissement Fran\u00e7ais du Sang-Grand Est F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-4961","authenticated-orcid":false,"given":"Anita","family":"Eckly","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 de Strasbourg, Strasbourg, France"},{"name":"2INSERM UMR_S1255, Strasbourg, France"},{"name":"3\u00c9tablissement Fran\u00e7ais du Sang-Grand Est F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3264-7330","authenticated-orcid":false,"given":"Blandine","family":"Ma\u00eetre","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 de Strasbourg, Strasbourg, France"},{"name":"2INSERM UMR_S1255, Strasbourg, France"},{"name":"3\u00c9tablissement Fran\u00e7ais du Sang-Grand Est F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"issue":"3","key":"2026012709415402600_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.hoc.2016.01.008","article-title":"Management of the platelet refractory patient","volume":"30","author":"Forest","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"2026012709415402600_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/vox.12411","article-title":"Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial","volume":"111","author":"Hess","year":"2016","journal-title":"Vox Sang"},{"issue":"4","key":"2026012709415402600_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tmrv.2020.09.010","article-title":"Human leukocyte antigen alloimmunization and alloimmune platelet refractoriness","volume":"34","author":"Saris","year":"2020","journal-title":"Transfus Med Rev"},{"issue":"1","key":"2026012709415402600_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/voxs.12073","article-title":"Managing the platelet refractory patient","volume":"9","author":"Murphy","year":"2014","journal-title":"ISBT Sci Ser"},{"issue":"1","key":"2026012709415402600_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1182\/hematology.2020000137","article-title":"Platelet transfusion refractoriness: how do I diagnose and manage?","volume":"2020","author":"Cohn","year":"2020","journal-title":"Hematology"},{"key":"2026012709415402600_bib6","doi-asserted-by":"crossref","first-page":"1125367","DOI":"10.3389\/fimmu.2023.1125367","article-title":"Anti-HLA class I alloantibodies in platelet transfusion refractoriness: from mechanisms and determinants to therapeutic prospects","volume":"14","author":"Couvidou","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"2026012709415402600_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3324\/haematol.2020.248385","article-title":"Fc\u03b3RI and Fc\u03b3RIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb\/IIIa autoantibody-opsonized platelets in immune thrombocytopenia","volume":"106","author":"Norris","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"2026012709415402600_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3324\/haematol.2018.201665","article-title":"Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets","volume":"104","author":"Rijkers","year":"2019","journal-title":"Haematologica"},{"issue":"14","key":"2026012709415402600_bib9","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2015-10-673426","article-title":"CD8+ T cells mediate antibody-independent platelet clearance in mice","volume":"127","author":"Arthur","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2026012709415402600_bib10","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood-2009-01-199414","article-title":"Role of sialic acid for platelet life span: exposure of \u03b2-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor\u2013expressing liver macrophages and hepatocytes","volume":"114","author":"S\u00f8rensen","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2026012709415402600_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jcp.34.4.377","article-title":"Spleen function and platelet kinetics","volume":"34","author":"Klonizakis","year":"1981","journal-title":"J Clin Pathol"},{"issue":"4","key":"2026012709415402600_bib12","doi-asserted-by":"crossref","first-page":"e20190723","DOI":"10.1084\/jem.20190723","article-title":"Macrophage galactose lectin is critical for Kupffer cells to clear aged platelets","volume":"217","author":"Deppermann","year":"2020","journal-title":"J Exp Med"},{"issue":"3","key":"2026012709415402600_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/imm.12469","article-title":"Human spleen microanatomy: why mice do not suffice","volume":"145","author":"Steiniger","year":"2015","journal-title":"Immunology"},{"issue":"21","key":"2026012709415402600_bib14","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr Biol"},{"issue":"8","key":"2026012709415402600_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2026012709415402600_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.07.007","article-title":"Sensing and clearance of apoptotic cells","volume":"68","author":"Nagata","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"14","key":"2026012709415402600_bib17","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1182\/bloodadvances.2022009423","article-title":"Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets","volume":"7","author":"Norris","year":"2023","journal-title":"Blood Adv"},{"issue":"25","key":"2026012709415402600_bib18","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood.2019003770","article-title":"Mechanisms of anti-GPIb\u03b1 antibody\u2013induced thrombocytopenia in mice","volume":"135","author":"Morodomi","year":"2020","journal-title":"Blood"},{"issue":"22","key":"2026012709415402600_bib19","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1182\/blood-2012-03-415695","article-title":"Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fc\u03b3 receptor for the amelioration of experimental ITP","volume":"119","author":"Leontyev","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2026012709415402600_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2141.2001.03136.x","article-title":"IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity","volume":"115","author":"Crow","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"2026012709415402600_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"Fc\u03b3RIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"issue":"8","key":"2026012709415402600_bib22","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1182\/bloodadvances.2022008411","article-title":"Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice","volume":"7","author":"Couvidou","year":"2023","journal-title":"Blood Adv"},{"issue":"9","key":"2026012709415402600_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/dvg.20335","article-title":"A global double-fluorescent Cre reporter mouse","volume":"45","author":"Muzumdar","year":"2007","journal-title":"Genesis"},{"issue":"4","key":"2026012709415402600_bib24","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2006-04-020362","article-title":"Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo","volume":"109","author":"Tiedt","year":"2007","journal-title":"Blood"},{"key":"2026012709415402600_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/1-59259-782-3:013","volume-title":"Platelets and Megakaryocytes: Volume 1: Functional Assays","author":"Cazenave","year":"2004"},{"issue":"19","key":"2026012709415402600_bib26","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM198605083141907","article-title":"Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody","volume":"314","author":"Clarkson","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"2026012709415402600_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"24","key":"2026012709415402600_bib28","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2015-09-671339","article-title":"Anti-mouse Fc\u03b3RIV antibody 9E9 also blocks Fc\u03b3RIII in vivo","volume":"126","author":"Tipton","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2026012709415402600_bib29","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/bloodadvances.2023012155","article-title":"Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP","volume":"8","author":"Gil Gonzalez","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"2026012709415402600_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"issue":"2","key":"2026012709415402600_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0022-1759(91)90015-8","article-title":"In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje","volume":"136","author":"Van den Berg","year":"1991","journal-title":"J Immunol Methods"},{"issue":"20","key":"2026012709415402600_bib32","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1182\/blood-2010-11-320028","article-title":"Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen","volume":"117","author":"McGaha","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2026012709415402600_bib33","doi-asserted-by":"crossref","first-page":"eadq6399","DOI":"10.1126\/sciadv.adq6399","article-title":"Splenic red pulp macrophages eliminate the liver-resistant Streptococcus pneumoniae from the blood circulation of mice","volume":"11","author":"An","year":"2025","journal-title":"Sci Adv"},{"issue":"10","key":"2026012709415402600_bib34","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3324\/haematol.2018.189365","article-title":"A subset of anti-HLA antibodies induces Fc\u03b3RIIa-dependent platelet activation","volume":"103","author":"Rijkers","year":"2018","journal-title":"Haematologica"},{"issue":"3","key":"2026012709415402600_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness \u2013 practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"issue":"4","key":"2026012709415402600_bib36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood.V64.4.937.937","article-title":"High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients","volume":"64","author":"Schiffer","year":"1984","journal-title":"Blood"},{"issue":"2","key":"2026012709415402600_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ajh.2830490213","article-title":"Treatment of platelet alloimmunization with intravenous immunoglobulin in a child with aplastic anemia","volume":"49","author":"Chen","year":"1995","journal-title":"Am J Hematol"},{"issue":"4A","key":"2026012709415402600_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0002-9343(87)90548-1","article-title":"Treatment of platelet alloimmunization with intravenous immunoglobulin. Two case reports and review of the literature","volume":"83","author":"Kurtzberg","year":"1987","journal-title":"Am J Med"},{"issue":"6","key":"2026012709415402600_bib39","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/trf.13598","article-title":"C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants","volume":"56","author":"Jackman","year":"2016","journal-title":"Transfusion"},{"issue":"4","key":"2026012709415402600_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tmrv.2019.09.003","article-title":"Complement as an immune barrier in platelet transfusion refractoriness","volume":"33","author":"Meinke","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"1","key":"2026012709415402600_bib41","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/ncomms8737","article-title":"Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"issue":"8","key":"2026012709415402600_bib42","doi-asserted-by":"crossref","first-page":"e155676","DOI":"10.1172\/jci.insight.155676","article-title":"Rasa3 deficiency minimally affects thrombopoiesis but promotes severe thrombocytopenia due to integrin-dependent platelet clearance","volume":"7","author":"Lee","year":"2022","journal-title":"JCI Insight"},{"issue":"5","key":"2026012709415402600_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","article-title":"The integrins","volume":"8","author":"Takada","year":"2007","journal-title":"Genome Biol"},{"issue":"2","key":"2026012709415402600_bib44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.41926","article-title":"Platelet phagocytosis via P-selectin glycoprotein ligand 1 and accumulation of microparticles in systemic sclerosis","volume":"74","author":"Manfredi","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"2026012709415402600_bib45","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1074\/jbc.M211282200","article-title":"Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin","volume":"278","author":"Hermand","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"2026012709415402600_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00418-020-01924-3","article-title":"Exploring human splenic red pulp vasculature in virtual reality: details of sheathed capillaries and the open capillary network","volume":"155","author":"Steiniger","year":"2021","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"2026012709415402600_bib47","doi-asserted-by":"crossref","first-page":"16487","DOI":"10.1038\/s41598-022-19885-z","article-title":"The human splenic microcirculation is entirely open as shown by 3D models in virtual reality","volume":"12","author":"Steiniger","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"2026012709415402600_bib48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI105380","article-title":"Pooling of platelets in the spleen: role in the pathogenesis of","volume":"45","author":"Aster","year":"1966","journal-title":"J Clin Invest"},{"issue":"2","key":"2026012709415402600_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.1977.tb06844.x","article-title":"The exchangeable splenic platelet pool in response to selective adrenergic beta-1-receptor blockade","volume":"37","author":"Kutti","year":"1977","journal-title":"Br J Haematol"},{"issue":"3","key":"2026012709415402600_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0609.1976.tb01177.x","article-title":"The peripheral platelet count in response to intravenous infusion of isoprenaline","volume":"17","author":"Olsson","year":"1976","journal-title":"Scand J Haematol"},{"issue":"8","key":"2026012709415402600_bib51","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.2631","article-title":"Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance","volume":"14","author":"Wong","year":"2013","journal-title":"Nat Immunol"},{"issue":"3","key":"2026012709415402600_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajh.2830220308","article-title":"The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation","volume":"22","author":"Banaji","year":"1986","journal-title":"Am J Hematol"},{"issue":"1","key":"2026012709415402600_bib53","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.4081\/pr.2016.6159","article-title":"The use of splenectomy to manage platelet transfusion refractoriness due to anti-human leukocyte antibodies in allogeneic stem cell transplantation","volume":"8","author":"Mauro","year":"2016","journal-title":"Pediatr Rep"},{"issue":"2","key":"2026012709415402600_bib54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/09537104.2014.895922","article-title":"Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness","volume":"26","author":"Cid","year":"2015","journal-title":"Platelets"},{"key":"2026012709415402600_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2017.04.009","article-title":"Flow cytometric quantitation of platelet phagocytosis by monocytes using a pH-sensitive dye, pHrodo-SE","volume":"447","author":"Takahashi","year":"2017","journal-title":"J Immunol Methods"},{"issue":"17","key":"2026012709415402600_bib56","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1182\/bloodadvances.2024014143","article-title":"Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients","volume":"8","author":"Boothby","year":"2024","journal-title":"Blood Adv"},{"key":"2026012709415402600_bib57","doi-asserted-by":"crossref","first-page":"1281123","DOI":"10.3389\/fimmu.2023.1281123","article-title":"Enhanced alloresponse to platelet transfusion due to immune dysregulation following ablative chemotherapy in mice","volume":"14","author":"Jackman","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"2026012709415402600_bib58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.trecan.2024.12.003","article-title":"Recent developments in myeloid immune modulation in cancer therapy","volume":"11","author":"Parvanian","year":"2025","journal-title":"Trends Cancer"},{"issue":"1-2","key":"2026012709415402600_bib59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tracli.2006.02.013","article-title":"Target cell CD47 regulates macrophage activation and erythrophagocytosis","volume":"13","author":"Olsson","year":"2006","journal-title":"Transfus Clin Biol"},{"issue":"21","key":"2026012709415402600_bib60","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1073\/pnas.93.21.11877","article-title":"In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function","volume":"93","author":"Michelson","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2026012709415402600_bib61","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1073\/pnas.1720553115","article-title":"Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration","volume":"115","author":"Cloutier","year":"2018","journal-title":"Proc Natl Acad Sci"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/2\/367\/2498056\/blooda_adv-2025-017175-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/2\/367\/2498056\/blooda_adv-2025-017175-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:42:06Z","timestamp":1769524926000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/2\/367\/547662\/Targeting-macrophages-prevents-alloantibody"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017175","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,27]]},"published":{"date-parts":[[2026,1,15]]}}}